Effect of Sulodexide in Early Diabetic Nephropathy

Clinical trial NCT00130208 · COMPLETED

Trial details

NCT number: NCT00130208
Sponsor: Keryx Biopharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Nephropathy

Start date: 2005-08-01
Primary completion: 2008-01-01
Enrollment: 1056

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.